Skip to main content

Table 1 Patients characteristics

From: Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus

Variable Group 1
ECMO
(n = 17)a
Group 2
Control
(n = 18)
P value
Age median [IQR] 45.5 [28.5–58.5] 50 [33–63.5] 0.484
Gender (male) n (%) 12 (70.6%) 11 (61.1%) 0.556
Weight (kg) 87.4 (25.4) 87.5 (21.4) 0.989
Height (cm) 167.4 (10.1) 161.6 (6.1) 0.100
Body surface area (kg/m−2) 1.95 (0.31) 1.90 (0.26) 0.712
APACHE II median [IQR]b 27.8 [23–29.8] 31 [24–29.5] 0.120
Pregnancy n (%) 1 (5.9%) 1 (5.6%) 0.493
Comorbidities n (%)
 Diabetes 8 (47.1%) 10 (55.6%) 0.616
 Hypertension 5 (29.1%) 7 (38.9%) 0.725
 Coronary artery disease 1 (5.9%) 1 (5.6%) 0.493
 Heart failure 0 (0%) 1 (5.6%) 0.975
 Bronchial asthma 2 (11.8%) 2 (11.1%) 0.638
 COPDc 2 (11.8%) 0 (0%) 0.442
 Acute kidney injury 2 (11.8%) 1 (5.6%) 0.975
 Chronic kidney disease 1 (5.9%) 4 (22.2%) 0.371
 Liver disease 0 (0%) 2 (11.1%) 0.493
 Immunocompromised 0 (0%) 1 (5.6%) 0.975
 Preexisting risk factors for ARDS n (%)d 0 (0%) 0 (0%)  
 Bacterial co-infection n (%) 7 (41.2%) 4 (22.2%) 0.401
  1. Data are presented as median [minimum–maximum], number (%), or mean (SD)
  2. aECMO extracorporeal membrane oxygenation
  3. bAPACHE II Acute Physiology and Chronic Health Evaluation score II
  4. cCOPD chronic obstructive pulmonary disease
  5. dARDS acute respiratory distress syndrome